Pharma News, 2025

Korean biotech leaders to take center stage at JP Morgan Healthcare Conference

Lilly doubles down on its presence in India with new capability center, plans to hire 1,000+

FDA CDER director Patrizia Cavazzoni announces resignation

Climb Bio ascends from Eliem legacy with $9M upfront deal for preclinical IgA antibody

Alzheimer’s Drugs Eyed as Next Big Obesity-Like Opportunity

Menarini Group Licenses Preclinical Oncology Asset from Insilico Medicine Agreement grants Stemline the global rights to develop and commercialize a preclinical small molecule targeting high unmet nee...

FDA Releases Draft Guidance on Confirmatory Trials for Accelerated Approvals

Resolute's RZ358 gains FDA recognition for groundbreaking treatment of hyperinsulinemia-related hypoglycemia

FDA Grants Fast Track Designation to Posdinemab for Early Alzheimer Disease

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

Quris-AI's Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.  The start of the new year is typically a time when people make big...